Collins Kevin M, Wickner William T
Department of Biochemistry, Dartmouth Medical School, 7200 Vail Building, Hanover, NH 03755-3844, USA.
Proc Natl Acad Sci U S A. 2007 May 22;104(21):8755-60. doi: 10.1073/pnas.0702290104. Epub 2007 May 14.
cis-SNARE complexes (anchored in one membrane) are disassembled by Sec17p (alpha-SNAP) and Sec18p (NSF), permitting the unpaired SNAREs to assemble in trans. We now report a direct assay of trans-SNARE complex formation during yeast vacuole docking. SNARE complex assembly and fusion is promoted by high concentrations of the SNARE Vam7p or Nyv1p or by addition of HOPS (homotypic fusion and vacuole protein sorting), a Ypt7p (Rab)-effector complex with a Sec1/Munc18-family subunit. Inhibitors that target Ypt7p, HOPS, or key regulatory lipids prevent trans-SNARE complex assembly and ensuing fusion. Strikingly, the lipid ligand MED (myristoylated alanine-rich C kinase substrate effector domain) or elevated concentrations of Sec17p, which can displace HOPS from SNARE complexes, permit full trans-SNARE pairing but block fusion. These findings suggest that efficient fusion requires trans-SNARE complex associations with factors such as HOPS and subsequent regulated lipid rearrangements.
顺式SNARE复合体(锚定在一个膜上)由Sec17p(α-SNAP)和Sec18p(NSF)拆解,使未配对的SNARE能够反式组装。我们现在报告了一种在酵母液泡对接过程中对反式SNARE复合体形成的直接检测方法。高浓度的SNARE蛋白Vam7p或Nyv1p,或添加HOPS(同型融合和液泡蛋白分选),一种带有Sec1/Munc18家族亚基的Ypt7p(Rab)效应复合体,可促进SNARE复合体的组装和融合。靶向Ypt7p、HOPS或关键调节脂质的抑制剂可阻止反式SNARE复合体的组装及随后的融合。引人注目的是,脂质配体MED(肉豆蔻酰化富含丙氨酸的C激酶底物效应结构域)或高浓度的Sec17p,可将HOPS从SNARE复合体中置换出来,能使反式SNARE完全配对,但会阻止融合。这些发现表明,高效融合需要反式SNARE复合体与HOPS等因子结合,并随后进行受调控的脂质重排。